|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 237/04 | (2006.01) |
| A61K 31/50 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 1248620 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00969616.2 |
| Date of filing the European patent application | 2000-10-20 | |
| (97) | Date of publication of the European application | 2002-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2004-11-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/FI2000/0009 |
| Date | 2000-10-20 |
| (87) | Number | WO 2001/028560 |
| Date | 2001-04-26 |
| (30) | Number | Date | Country code |
| 992298 | 1999-10-22 | FI |
| (72) |
LEHTONEN, Lasse, FI
RUDA, Mikhail, c/o Russian Cardiology, RU
HOSENPUD, Jeffrey, St. Luke`s Medical Center, US
|
| (73) |
Orion Corporation,
Orionintie 1, 02200 Espoo,
FI
|
| (54) | A NEW USE OF LEVOSIMENDAN |
| A NEW USE OF LEVOSIMENDAN |